Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Sanofi to build vaccine plant in China
Vaccines made in China--for China. Sanofi Pasteur says it's spending about $104 million on a Chinese manufacturing plant in hopes of launching flu shots locally by 2012. The plant will be in Shenzhen, South China, where the company already operates a filling and packing facility. Construction on the plant will start next year. When it's up and running, it will have 100 employees and a capacity of 25 million doses, but Sanofi hopes to double that within 10 to 15 years.
- read the report from Dow Jones
Related Articles:
Sanofi signs stem cell pact in China. Report
Sanofi vaccine effective against new bird flu strains. Report
China pushes drug development as R&D soars. Report
Be the first to comment
More stories about drug development
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
